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Myocyte-speci®c enhancer-binding factor 2 (MEF2) is a myogenic regulatory factor in vertebrates and Drosophila. Whereas
the role of MEF2 in regulating vertebrate myogenesis and muscle genes has been extensively studied, little is known of
the role of MEF2 in regulating Drosophila myogenesis. We have shown in a recent analysis of the regulation of the
Drosophila Tropomyosin I (TmI) gene in transgenic ¯ies that MEF2 is a positive regulator of TmI expression in the somatic
body-wall muscles of embryos, larvae, and adults. To understand further the role of MEF2 in myogenesis and test the role
of MEF2 in regulating TmI expression, we have used the yeast GAL4/UAS system to generate embryos in which MEF2 is
ectopically expressed in tissues where it is not normally expressed or embryos in which MEF2 is overexpressed in the
mesoderm and muscles. We observe that ectopic expression of MEF2 in the epidermis and the ventral midline cells in
embryos activates the expression of TmI and other muscle genes in these tissues and that this activation is stage-dependent
suggesting a requirement for additional factors. Furthermore, ectopic expression of MEF2 in the epidermis results in a
decrease in the expression of signaling molecules in the epidermis and a failure of the embryo to properly form body-wall
muscles. These results indicate that MEF2 can function out of context in the epidermis to induce the expression of muscle
genes and interfere with a requirement for the epidermis in muscle development. We also ®nd that the level of MEF2 in
the mesoderm and/or muscles in embryos is critical to body-wall muscle formation; however, no effect is observed on the
development of the visceral muscle or dorsal vessel. q 1997 Academic Press
INTRODUCTION closest known Drosophila homologue of the vertebrate
myogenic factor family (Michelson et al., 1990; Paterson et
al., 1991). However, mutation analyses of the nau gene haveMuch of our knowledge about skeletal muscle develop-
revealed that the function of nau is probably limited to onlyment has come from the cloning of the vertebrate myogenic
a subset of body-wall muscle precursors (Abmayr et al.,family of basic helix±loop±helix (bHLH) proteins. This
1995).family contains four muscle-speci®c transcription factors,
A second factor important in regulating vertebrate myo-MyoD, Myf5, MRF4, and Myogenin. Cell culture studies
genesis is myocyte-speci®c enhancer-binding factor 2have shown that each of these myogenic bHLH proteins
(MEF2). MEF2 was initially identi®ed as a DNA-bindingis able to activate skeletal muscle-gene transcription and
activity that was induced when skeletal myoblasts differen-skeletal muscle differentiation when expressed in a variety
tiated into myotubes (Gossett et al., 1989). It recognizes anof non-muscle-cell types (reviewed in Olson and Klein,
AT-rich sequence shown to be important for the activation1994). The roles of these factors in muscle development
of many muscle genes in differentiating myotubes. MEF2have been con®rmed by gene-knockout experiments in
belongs to the MADS (MCM1, Agamous, De®ciens, andmice (Braun et al., 1992; Hasty et al., 1993; Nabeshima et
serum response factor) box-containing family of transcrip-al., 1993; Rudnicki et al., 1993). nautilus (nau) encodes the
tion factors (reviewed in Shore and Sharrocks, 1995). Four
mef2 genes have been identi®ed in vertebrates (Pollock and
Treisman, 1991; Yu et al., 1992; Breitbart et al., 1993; Mar-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (312) 413-0364. tin et al., 1993, 1994; McDermott et al., 1993; Chambers
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et al., 1994; reviewed in Olson et al., 1995). Their products suf®cient by itself to direct TmI enhancer-directed expres-
sion in muscles. Thus the function of MEF2 in regulatingshare more than 85% amino-acid homology within the
MADS box and the adjacent conserved region referred to as Drosophila muscle genes and differentiation is likely to be
complex and involve multiple interacting factors. One waythe MEF2 domain. MEF2 recognizes a consensus (C/T)T(A/
T)2AAATA(A/G) sequence through the MADS box and the to gain insight into the possible function of MEF2 is to
generate gain-of-function mutations by expressing MEF2 inMEF2 domain (Gossett et al., 1989; Pollock and Treisman,
1991; Yu et al., 1992; Breitbart et al., 1993; Martin et al., tissues where it is not normally expressed. Another is to
modulate the level of expression of MEF2 in the tissue in1993; McDermott et al., 1993). Several studies have shown
that MEF2 plays an important role in the transcriptional which it is normally expressed and thus alter its interaction
with other regulatory molecules. We therefore testedregulation of the myogenic bHLH genes (Edmondson et al.,
1992; Yee and Rigby, 1993; Buchbager et al., 1994; Leibham whether ectopic expression of MEF2 in other tissues could
activate ectopic expression of TmI and other muscle geneset al., 1994; Black et al., 1995; Naidu et al., 1995) and other
muscle genes (Bassel-Duby et al., 1992; Morisaki and and whether elevated levels of MEF2 in the mesoderm and
muscles have any effect on normal muscle differentiation.Holmes, 1993; Chambers et al., 1994; Kaushal et al., 1994;
Li and Capetanaki, 1994; Liu et al., 1994; Parmacek et al., In this report, we used the yeast GAL4/UAS system to ex-
press MEF2 in different tissues (Brand and Perrimon, 1993).1994; Andres et al., 1995; Molkentin et al., 1995). mef2
genes are expressed in skeletal, cardiac, and smooth muscles We ®nd that ectopically expressing MEF2 in the epidermis
and the ventral midline cells of embryos results in the tran-during mouse development, suggesting that they may play
important roles in activating transcription within each scriptional activation of TmI and other muscle genes. These
results are discussed in terms of the possible requirementmyogenic lineage (Edmondson et al., 1994).
The analysis of MEF2 functions has been facilitated by for additional factors present in the epidermis to activate
muscle genes. In addition, ectopic expression of MEF2 inthe isolation and characterization of the mef2 gene in Dro-
sophila (Lilly et al., 1994; Nguyen et al., 1994; Taylor et the epidermis results in a failure of the embryo to form
body-wall muscles and a decrease in the expression of sig-al., 1995). Drosophila contains a single mef2 gene that en-
codes a protein having greater than 85% amino-acid homol- naling molecules in the epidermis, suggesting a require-
ment for the epidermis in muscle development. We alsoogy within the MADS box and the MEF2 domain to the
corresponding regions of vertebrate MEF2 proteins. It recog- ®nd that the level of MEF2 in the mesoderm and/or muscles
is critical to body-wall muscle formation. An increase innizes the same target sequence as its vertebrate homologues
and can transactivate reporter constructs in transient trans- the level of MEF2 in the mesoderm leads to embryonic
lethality and defective body-wall muscle formation.fection assays in a MEF2-binding site-dependent manner.
Drosophila mef2 is expressed in the mesoderm of early em-
bryos shortly after gastrulation, and continues to be ex-
pressed in somatic, visceral, and cardiac muscle lineages MATERIALS AND METHODS
throughout embryogenesis. This pattern of expression sug-
gests that mef2 may be important in regulating the earlier Drosophila Stocks and Crosses to Ectopically
Express MEF2stages of myogenesis that establish mesoderm and muscle
lineages as well as the later stages of myogenesis that regu-
Fly stocks were maintained at 22 or 257C on standard media
late myoblast differentiation. Mutations of the mef2 gene, (Carolina Biological Supply Company). The GAL4-expressing lines
however, suggest that the role(s) of mef2 in regulating Dro- 24B, 69B, hsGAL42-1 (Brand and Perrimon, 1993), and GAL4-1407
sophila myogenesis may be limited to later aspects of myo- (Luo et al., 1994), and the UAS-mef2 line (Bour et al., 1995) have
genesis because mef2 null mutant embryos show normal been described. To direct expression of MEF2 in a tissue-speci®c
way, the 24B, 69B, or GAL4-1407 enhancer lines expressing GAL4speci®cation and patterning of muscle precursors (Bour et
were crossed to the UAS-mef2 line and embryos from these crossesal., 1995; Lilly et al., 1995; Ranganayakulu et al., 1995).
were collected for 16 hr at 257C or 13 hr at 297C on grape-agarThese muscle precursors, however, fail to undergo fusion
plates. To heat-induce expression of MEF2 in embryos, theand differentiation to form muscle ®bers.
hsGAL42-1 line was crossed to the UAS-mef2 line and heat-shockWe have recently demonstrated a role for MEF2 in the
treatments were carried out as follows. Embryos from this crosstranscriptional regulation of the Drosophila Tropomyosin
were collected for 2 hr at 257C, aged for 2 hr at 257C, and then
(TmI) gene during muscle ®ber differentiation. The TmI placed for 30 min in a 377C water bath, followed by a 30-min
gene contains two partially redundant muscle enhancers incubation at room temperature. The heat-shock treatment was
within the ®rst intron. Both enhancers can drive high-level repeated once more and embryos were aged at 257C for 0, 2, 4, 6,
expression of reporter genes in muscles of transgenic em- 8, 10, or 12 more hours before ®xation for immunohistochemical
staining and in situ hybridization.bryos, larvae, and adults (Schultz et al., 1991; Gremke et
al., 1993; Lin et al., 1996). Furthermore, both enhancers
contain a MEF2-binding site and mutation of either MEF2-
Immunohistochemical Staining of Whole-Mountbinding site leads to a dramatic decrease in the enhancer-
Embryosdirected reporter gene expression in muscles of transgenic
¯ies (Lin et al., 1996). Additional experiments indicate, Ectopically expressed MEF2 protein was determined by immuno-
histochemical staining as described (Hoshizaki, 1994). Polyclonalhowever, that the MEF2-binding site while necessary is not
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MEF2 antibody (Bour et al., 1995) was used at a 1:1000 dilution. null mutant embryos do not make body-wall muscles (Bour
Goat anti-rabbit IgG conjugated with alkaline phosphatase (Sigma) et al., 1995; Lilly et al., 1995; Ranganayakulu et al., 1995)
was used at a 1:500 dilution. In each GAL4 enhancer 1 UAS-mef2 and do not express TmI (Lin et al., 1995). Accordingly, we
cross high levels of MEF2 were detected at the stages and tissues considered the possibility that gain-of-function mutations
dictated by the GAL4 enhancer construct (Brand and Perrimon, might be generated by ectopic expression of MEF2 through
1993; Luo et al., 1994; see below).
activation of part or all of the myogenic program and TmI
expression in tissues where it is not normally expressed.
We tested this possibility by ectopic expression of MEF2Whole-Mount in Situ Hybridization of Embryos
in the epidermis and nervous system using the yeast
Whole-mount in situ hybridization using antisense RNA as a
GAL4/UAS system. In this system transgenic ¯ies con-probe was done as described (Tautz and Pfei¯e, 1989; Jiang et al.,
taining a mef2 cDNA clone under the control of yeast up-1991). Antisense RNA probes were synthesized using a digoxi-
stream activator sequence (UAS) are crossed to transgenicgenin-labeled uracil analogue as described by the manufacturer
¯ies containing a GAL4 cDNA clone driven by a tissue-(Boehringer-Mannheim). TmI antisense RNA was prepared from a
speci®c genomic enhancer or a heat-inducible enhancer2.3-kb TmI genomic DNA inserted into pGem-1 which contains
sequence from exon 2 to exon 5 (Basi and Storti, 1986). The plasmid (Brand and Perrimon, 1993). The 69B epidermal enhancer
was linearized by digestion with HindIII and transcribed using T7 line expresses GAL4 in epidermal precursors beginning at
RNA polymerase. Antisense b3-Tubulin (b3-Tub) RNA was synthe- late stage 9 and then in the epidermis (Brand and Perrimon,
sized from a 0.6-kb b3-Tub cDNA cloned into pGem-1 at the PstI± 1993). It also expresses GAL4 in a set of ventral midline
SacI site (Gasch et al., 1988). The plasmid was linearized by diges- cells underneath the epidermis starting at stage 10. While
tion with PstI and transcribed using T7 RNA polymerase. Anti- the identities of these ventral midline cells are unknown,
sense S59 RNA was synthesized from a 2.6-kb S59 cDNA (Dohr-
their position in the mid-ventral region of the embryo sug-mann et al., 1990). The plasmid was linearized by digestion with
gests that they may be ectodermally derived neuroblast pre-PstI and transcribed using T3 RNA polymerase. Antisense nau
cursors that give rise to midline glial cells. Embryos ob-RNA was synthesized from a 1.3-kb nau cDNA cloned into pBlue-
tained from the cross of ¯ies carrying the 69B epidermalscript KS at the EcoRI site (Michelson et al., 1990). The plasmid
was linearized by digestion with BamHI and transcribed using T3 enhancer to ¯ies carrying the UAS-mef2 transgene ex-
RNA polymerase. Antisense DMLP1 RNA was synthesized from a pressed high levels of MEF2 in the epidermal precursors and
0.5-kb DMLP1 cDNA cloned into pBluescript SK at the EcoRI site the ventral midline cells from stage 10 onward (not shown)
(Arber et al., 1994). The plasmid was linearized by digestion with as determined by MEF2 antibody staining. These embryos
XhoI and transcribed using T3 RNA polymerase. Antisense aPS1 did not hatch and died as late embryos and showed no tra-
integrin RNA (Leptin et al., 1989) was synthesized from a 5-kb
chea formation and no body-wall movement. These em-
aPS1 cDNA clone obtained from Dr. T. Bunch. The plasmid was
bryos also showed a failure to undergo dorsal closure, re-linearized by digestion with HindIII and transcribed using T7 RNA
sulting in a large opening on the dorsal side, through whichpolymerase. Antisense aPS2 integrin RNA (Bogaert et al., 1987) was
the gut was extruded (Fig. 1E). In embryos in which MEF2synthesized from a 4.4-kb aPS2 cDNA clone obtained from Dr. R.
was ectopically expressed in the epidermis and the ventralSchulz. The plasmid was linearized by digestion with XhoI and
transcribed using T3 RNA polymerase. Antisense crumbs (crb) midline cells, TmI expression was detected in these two
RNA was synthesized from an 6-kb crb cDNA subclone of crb- tissues as well as in muscles. The ectopic expression of TmI
pUAST (Tepass and Knust, 1993) inserted into pGEM-3Zf at the in the epidermis was observed beginning at stage 13 and
EcoRI±XbaI site. The plasmid was linearized by digestion with persisted at later stages. The ectopic expression was de-
EcoRI and transcribed using SP6 RNA polymerase. Antisense deli- tected uniformly throughout the epidermis and most clearly
lah (dei) RNA was synthesized from a 1.3-kb dei cDNA cloned into
seen on the ventral side due to the absence of underlyingpBluescript KS at the EcoRI site (Armand et al., 1994). The plasmid
muscles expressing TmI (compare Figs. 1B and 1D with 1Awas linearized by digestion with BamHI and transcribed using T3
and 1C, respectively) and the anterior and posterior regionsRNA polymerase. Antisense decapentaplegic (dpp) RNA was syn-
(Fig. 1E) of the embryo where there was less underlying TmIthesized from an 3-kb dpp cDNA clone obtained from Dr. E. L.
transcript in muscles. The ectopic expression of TmI in theFerguson (Ferguson and Anderson, 1992). The plasmid was linear-
ized by digestion with BamHI and transcribed using T7 RNA poly- ventral midline cells was also observed starting at stage 13
merase. The 2.9-kb wingless (wg) cDNA in pSP65 (Rijsewijk et al., and was strongest at stage 15 (Fig. 1F). These results indicate
1987) was subcloned into pGEM-3Zf at the BamHI site. The plas- that MEF2 can function to induce TmI expression in the
mid was linearized by digestion with EcoRI and transcribed using epidermis and the ventral midline cells.
SP6 RNA polymerase to make antisense wg RNA. Embryos that ectopically expressed MEF2 in the epider-
mis and the ventral midline cells also showed ectopic ex-
pression of other muscle genes such as b3-Tub, nau, andRESULTS
aPS2 genes in these two tissues and the DMLP1 gene in the
ventral midline cells. b3-Tub encodes a cytoskeletal proteinEctopic Expression of MEF2 in Epidermis and found in myoblasts, muscle cells, and some nonmuscle cells
Ventral Midline Cells Results in Ectopic (Gasch et al., 1988; Leiss et al., 1988). It is expressed in
Expression of TmI and Other Muscle Genes normal embryos in the somatic mesoderm beginning at
stage 11 when the germ band is fully extended. Its expres-MEF2 functions as a positive regulator of TmI gene tran-
scription in developing muscle (Lin et al., 1995) and mef2 sion persists during germ-band retraction and can be fol-
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FIG. 1. Ectopic expression of TmI in embryos that ectopically express MEF2 in the epidermis and the ventral midline cells. Embryos
obtained from the cross of ¯ies carrying the 69B epidermal enhancer to ¯ies carrying the UAS-mef2 transgene were assayed for TmI
expression by whole-mount in situ hybridization. All embryos are stage 15 and oriented with the anterior to the left. (A) Wild-type UAS-
mef2 embryo, ventral view. No ectopic TmI expression is detected in the epidermis of the embryo. TmI expression in the ventral body-
wall muscles lateral to the ventral midsection of the embryo and beneath the epidermis is out of focus. (B) Ectopic MEF2 embryo, ventral
view. Ectopic expression of TmI is seen clearly in the epidermis of the ventral side of the embryo. The ectopic expression of TmI in the
anterior and lateral epidermis and ventral midline cells beneath the epidermis (arrow) is out of focus. C and D are higher magni®cations
of A and B, respectively. (E) Ectopic MEF2 embryo, dorsal view. Ectopic expression of TmI is seen clearly in the epidermis in the anterior
and posterior regions on the dorsal side of the embryo. A failure in dorsal closure, which leads to extrusion of the gut, is also observed.
(F) Ectopic MEF2 embryo, ventral view. Ectopic expression of TmI is observed in the ventral midline cells (arrow). TmI expression in the
thoracic and anterior abdominal epidermis is out of focus.
lowed into somatic muscle ®bers at later stages (Gasch et sion continued to later stages and was most obvious in the
ventral epidermal and midline cells (compare Figs. 2B andal., 1988; Leiss et al., 1988). In embryos that ectopically
expressed MEF2 in the epidermis and the ventral midline 2D with 2A and 2C, respectively) and the anterior and poste-
rior regions of the epidermis (not shown). nau is expressedcells, the ectopic expression of b3-Tub in these tissues was
®rst observed at stage 12 following the stage when b3-Tub in a subset of body-wall muscle precursor cells at late germ-
band extension (Michelson et al., 1990; Paterson et al.,is normally activated in the mesoderm. The ectopic expres-
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1991) and is required for the transition of these cells into Embryos derived from the cross of ¯ies carrying the 69B
epidermal enhancer to ¯ies carrying the UAS-mef2syncytial muscle ®bers (Abmayr et al., 1995). In embryos
that ectopically expressed MEF2 in the epidermis and ven- transgene expressed MEF2 ectopically in the epidermal pre-
cursors and the ventral midline cells from stage 10 onwardtral midline cells, nau was also expressed in these tissues;
however, the ectopic expression of nau was not detected as examined by MEF2 antibody staining (not shown). How-
ever, the ectopic expression of TmI and the other muscleuntil stage 14, later than when nau is ®rst detected in the
mesoderm in normal embryos. In addition, the ectopic ex- genes tested in the epidermis and the ventral midline cells
was not detected until stage 12 or later after stages whenpression appeared mostly in the epidermis of the head re-
gion (compare Fig. 2F with 2E), the ventral midline cells they are normally activated in the mesoderm. One explana-
tion for this delayed activation is that the accumulated levellocated in the anterior region (not shown), and at a lower
level in the epidermis of the body wall (compare Fig. 2H of ectopically expressed MEF2 in the epidermis and the ven-
tral midline cells at earlier stages is not suf®cient to activatewith 2G). aPS2 encodes the a subunit of muscle integrin and
its transcripts are detected in the mesoderm in early-stage ectopic expression of muscle genes in these tissues. An al-
ternative possibility, however, is that some other factor(s)embryos and then in the visceral and somatic muscles in
late-stage embryos (Bogaert et al., 1987; Leptin et al., 1989). not present in the epidermis and the ventral midline cells
until stage 12 or later is needed to act in conjunction withIn embryos that ectopically expressed MEF2 in the epider-
mis and the ventral midline cells, the ectopic expression of MEF2 to induce ectopic expression of muscle genes in these
tissues. We tested these possibilities by crossing ¯ies car-aPS2 was detected in the ventral midline cells starting at
stage 13 and reached maximum by stage 15 (compare Fig. 2L rying the hsGAL42-1 enhancer to ¯ies carrying the UAS-
mef2 transgene and heat-shocking embryos obtained at gas-with 2K) and detectable at about stage 16 in the epidermis of
the head region (compare Fig. 2J with 2I). DMLP1 encodes trulation to induce ectopic expression of MEF2 at earlier
stages. These heat-shocked embryos had a phenotype simi-a Drosophila homologue of the vertebrate muscle LIM pro-
tein which is a positive regulator of myogenic differentia- lar to ¯ies carrying the 69B epidermal enhancer and the
UAS-mef2 transgene in that they died late in embryogene-tion (Arber et al., 1994). DMLP1 transcripts are detected in
the visceral and somatic mesoderms in normal embryos sis, and did not show tracheal formation, or body-wall
movement. Furthermore, they also showed a defect in dor-starting at stage 13 (Arber et al., 1994). In contrast to the
above, ectopic expression of DMLP1 was observed only in sal closure, resulting in a large opening on the dorsal side.
Non-heat-shocked embryos from the same cross or wild-the ventral midline cells but not in the epidermis of em-
bryos that ectopically expressed MEF2 in the epidermis and type embryos heat-shocked at gastrulation were only
slightly affected since more than 80% of the embryos grewventral midline cells. The ectopic expression of DMLP1 in
the ventral midline cells was detected starting at stage 13 to adults.
The heat-shocked embryos from the cross of ¯ies carryingwhen DMLP1 is normally activated in the mesoderm and
peaked at about stage 15 (compare Fig. 2N with 2M). An- the hsGAL42-1 enhancer to ¯ies carrying the UAS-mef2
transgene showed strong ectopic expression of MEF2 in theother muscle gene examined, S59, a homeobox gene that is
expressed at late germ-band extension in a small subset presumptive epidermis and amnioserosa cells by stage 7
which reached maximum between stages 8 and 12 (Fig. 3A).of myoblasts that give rise to three muscles in abdominal
hemisegments 2 to 8 (Dohrmann et al., 1990), did not show Ectopic expression of TmI in the epidermis, however, was
not observed until stage 12 (Figs. 3B±3D). We also examinedany ectopic expression in the epidermis or the ventral mid-
line cells of these embryos. these heat-shock embryos for MEF2 induction of nau and
FIG. 2. Ectopic expression of b3-Tub, nau, aPS2, and DMLP1 in embryos that ectopically express MEF2 in the epidermis and the ventral
midline cells. Embryos derived from the cross of ¯ies carrying the 69B epidermal enhancer to ¯ies carrying the UAS-mef2 transgene were
assayed for expression of b3-Tub (A±D), nau (E±H), aPS2 (I±L), and DMLP1 (M and N) by whole-mount in situ hybridization. All embryos
are stage 15 and oriented with the anterior to the left. (A) Wild-type UAS-mef2 embryo, ventral view. No ectopic b3-Tub expression is
detected in the epidermis. (B) Ectopic MEF2 embryo, ventral view. Ectopic expression of b3-Tub is observed in the epidermis and the
ventral midline cells (arrow; out of focus) beneath the epidermis. C and D are higher magni®cations of A and B, respectively. (E) A higher
magni®cation of a dorsal view of a wild-type UAS-mef2 embryo. nau expression is seen in the body-wall muscle of the ®rst thoracic
segment. No ectopic expression of nau is detected in the epidermis of the head. (F) A higher magni®cation of a dorsal view of an ectopic
MEF2 embryo. Ectopic expression of nau is seen in the epidermis of the head. (G) A higher magni®cation of a lateral view of a wild-type
UAS-mef2 embryo. No ectopic expression of nau is detected in the epidermis on the lateral side of the body wall. (H) A higher magni®cation
of a lateral view of an ectopic MEF2 embryo. Ectopic expression of nau is detected in the epidermis on the lateral side of the body wall.
(I) A higher magni®cation of a dorsal view of a wild-type UAS-mef2 embryo. No ectopic aPS2 expression is detected in the epidermis of
the head region. (J) A higher magni®cation of a dorsal view of an ectopic MEF2 embryo. Ectopic expression of aPS2 is observed in the
epidermis of the head region. (K) Wild-type UAS-mef2 embryo, ventral view. No ectopic aPS2 expression is detected in the ventral midline
cells. (L) Ectopic MEF2 embryo, ventral view. Ectopic expression of aPS2 is observed in the ventral midline cells (arrow). (M) Wild-type
UAS-mef2 embryo, ventral view. No ectopic DMLP1 expression is detected in the ventral midline cells. (N) Ectopic MEF2 embryo, ventral
view. Ectopic expression of DMLP1 is observed in the ventral midline cells (arrow).
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shown). These embryos showed no gross defects in formation
of the central and peripheral nervous systems using the
monoclonal antibody 22C10 (not shown) which recognizes
a cell-surface neuronal antigen (Fujita et al., 1982). Thus
MEF2 in the nervous system affects dorsal closure and sur-
vival and may affect innervation leading to slow body-wall
movement. MEF2 expression in the nervous system, how-
ever, is not suf®cient to activate muscle gene expression.
Ectopic Expression of MEF2 in Epidermis and
Ventral Midline Cells Results in AbnormalFIG. 3. Ectopic expression of MEF2 and TmI in the epidermis of
Body-Wall Muscle Formationembryos by heat shock. Embryos derived from the cross of ¯ies
carrying the hsGAL42-1 enhancer to ¯ies carrying the UAS-mef2 In addition to the ectopic expression of TmI in the epider-
transgene were heat-shocked at gastrulation and assayed for the
mis and the ventral midline cells, the pattern of TmI expres-expression of MEF2 (A) by antibody staining using a serum con-
sion in the body-wall muscle of embryos ectopically ex-taining MEF2 antibody and for the expression of TmI (B±D) by
pressing MEF2 in the epidermis and the ventral midlinewhole-mount in situ hybridization. All embryos are oriented with
cells was abnormal. In a typical embryo, only muscle VA2the anterior to the left. (A) Stage 8, lateral view. Ectopic expression
(nomenclature according to Bate, 1993) showed a nearly nor-of MEF2 is observed in the nuclei of the presumptive epidermis
and amnioserosa cells which are located dorsally and less packed mal level of TmI expression among the ventral group of
than the presumptive epidermis. (B) Stage 10 heat-shocked embryo, body-wall muscles, although muscle VA2 was much shorter
lateral view. Ectopic expression of TmI is not detected in the epider- than the equivalent muscle of wild-type embryos (compare
mis. (C) Early stage 12 heat-shocked embryo, lateral view. Ectopic Fig. 4B with 4A). The other ventral group muscles showed
expression of TmI is detected in the epidermis. (D) A higher magni- a substantially decreased level of TmI expression (compare
®cation of C. TmI expression in the underlying developing muscles
Fig. 4D with 4C). The few muscles located at the mostis not detected until slightly later at late stage 12.
ventral region, VO4 to VO6, were also much shorter than
the equivalent muscles of wild-type embryos and they were
often fused to one another. The four lateral group body-
wall muscles, LT1, LT2, LT3, and LT4 (or possibly DT1),b3-Tub. b3-Tub and nau showed epidermal expression be-
ginning at stages 12 and 16, respectively (not shown), which expressed TmI but were disorganized (compare Fig. 4F with
4E). The other lateral group muscles, on the other hand,is the same as the results obtained from embryos carrying
the 69B epidermal enhancer and the UAS-mef2 transgene. were not visualized by detection of TmI expression (com-
pare Fig. 4H with 4G). It is possible that these musclesThese results suggest that even though MEF2 can be acti-
vated and accumulated to high levels in the epidermis of were missing or unable to express TmI. Similarly, several
muscles of the dorsal group body-wall muscles in these em-earlier stage embryos, MEF2 is not suf®cient to activate
TmI and that another factor(s) is required which is not pres- bryos were not visualized by detection for TmI expression
(not shown). The defective muscle formation would accountent in the epidermis until stage 12.
As an additional test of the above we examined TmI ex- for the fact that these embryos showed no movement. The
formation of the viscera and dorsal vessel, on the otherpression in ¯ies in which MEF2 is ectopically expressed in
the nervous system. The GAL4-1407 neuronal enhancer line hand, appeared normal and thus was not severely affected
by ectopic expression of MEF2 in the epidermis and theexpresses GAL4 in neuroblasts beginning at stage 10 and
subsequently in most neurons of the central nervous system ventral midline cells.
and all neurons in the peripheral nervous systems (Luo et
al., 1994). In embryos obtained from the cross of the GAL4- Effect of Ectopic Expression of MEF2 in Epidermis1407 neuronal enhancer to ¯ies carrying the UAS-mef2
and Ventral Midline Cells on Myoblast Patterningtransgene we observed high levels of MEF2 in the nervous
system comparable to that observed in the epidermis of em- Ectopic expression of MEF2 in the epidermis and the ven-
tral midline cells of embryos results in abnormal body-wallbryos carrying the 69B epidermal enhancer and the UAS-
mef2 transgene. However, in contrast to experiments in muscle formation as examined by TmI expression in mus-
cles. To test whether these embryos have a disrupted my-which MEF2 is ectopically expressed in the epidermis and
the ventral midline cells, embryos which expressed MEF2 oblast population, we analyzed by whole-mount in situ hy-
bridization the expression of b3-Tub which serves as aectopically in the nervous system never showed ectopic ex-
pression of TmI or any other muscle markers in neurons, marker of myoblasts. In embryos that ectopically expressed
MEF2 in the epidermis and the ventral midline cells, theand showed normal muscle morphology and TmI expression
levels in muscles (not shown). These embryos, however, died expression of b3-Tub in the mesoderm and muscle in late
germ-band retraction appeared to be normal (Figs. 5A andat late stages. They had normal looking trachea and slow
body-wall movement. They also showed incomplete dorsal 5B). However, its expression at later stages during body-wall
muscle formation was abnormal (not shown) and similar toclosure, resulting in a small opening on the dorsal side (not
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To further assess how body-wall muscles were abnor-
mally formed in these embryos, we examined muscle pre-
cursor cells for their expression of nau and S59. In embryos
in which MEF2 was ectopically expressed in the epidermis
and the ventral midline cells, the expression of nau in the
mesoderm was moderately reduced compared to wild-type
embryos beginning at stage 11 when nau is normally acti-
vated in the mesoderm (compare Fig. 5D with 5C). The
reduction became more distinct, however, in the body-wall
muscle at the end of germ-band shortening (compare Fig.
5F with 5E). The reduced level of nau expression in the
mesoderm could in part account for the defects in the forma-
tion of some nau-expressing muscle ®bers in these embryos;
e.g., VO4 to VO6 were shorter and often fused to one an-
other and showed a reduced level of TmI expression (Fig.
4D). The expression of S59 in these embryos, on the other
hand, appeared to be normal (not shown), consistent with
the results described earlier that muscles VA2 and possibly
DT1, two S59-expressing muscle ®bers, were formed in
these embryos. These results suggest that the formation of
the general myoblast population in embryos that ectopi-
FIG. 4. Abnormal body-wall muscle formation in embryos that
ectopically express MEF2 in the epidermis and the ventral midline
cells. Embryos obtained from the cross of ¯ies carrying the 69B
epidermal enhancer to ¯ies carrying the UAS-mef2 transgene were
assayed for TmI expression by whole-mount in situ hybridization.
All embryos are stage 17 with abdominal muscles viewed at high
magni®cations and oriented with the anterior to the left. (A) Wild-
type UAS-mef2 embryo, ventrolateral view. Muscles VA1 and VA2
of the ventral group body-wall muscles (bracket) are visualized by
TmI expression. (B) Ectopic MEF2 embryo, ventrolateral view. Mus-
cle VA1 of the ventral group body-wall muscles (bracket) is missing.
Muscle VA2 (arrow) is much shorter than that found in wild-type
embryos and shows a nearly normal level of TmI expression. (C)
A deeper focal plane of A. The other underlying ventral group body-
wall muscles are now visualized by TmI expression. The three
muscles located most ventrally, VO4 to VO6, are indicated. (D) A
FIG. 5. Expression of b3-Tub and nau in the mesoderm and mus-deeper focal plane of B. The other ventral group body-wall muscles
cles in embryos that ectopically express MEF2 in the epidermisshow a substantially decreased level of TmI expression, e.g., mus-
and the ventral midline cells. Embryos derived from the cross ofcles VO4 to VO6 (bracket). Muscles VO4 to VO6 are also much
¯ies carrying the 69B epidermal enhancer to ¯ies carrying the UAS-shorter than those found in wild-type embryos and often fused to
mef2 transgene were assayed for expression of b3-Tub (A and B)one another. (E) Wild-type UAS-mef2 embryo, lateral view. Muscles
and nau (C±F) by whole-mount in situ hybridization. All embryosLT1 to LT4 of the lateral group body-wall muscles (bracket) and
are oriented with the anterior to the left. (A) Wild-type UAS-mef2muscle DT1 of the dorsal group body-wall muscles are visualized
embryo, stage 12, lateral view. b3-Tub is detected in the body-wallby TmI expression. (F) Ectopic MEF2 embryo, lateral view. TmI is
muscle (arrowhead) and the visceral muscle (arrow). (B) Ectopicexpressed in muscles LT1 to LT3 (small bracket) of the lateral group
MEF2 embryo, stage 12, lateral view. b3-Tub expression in thebody-wall muscles (large bracket); however, these muscles are dis-
body-wall muscle and the visceral muscle appears normal. Someorganized. Another TmI-expressing muscle observed is possibly
of the out of focus staining is due to the ectopic expression of b3-LT4 or DT1 (arrow). (G) A deeper focal plane of E. The other under-
Tub in the epidermis. (C) Wild-type UAS-mef2 embryo, stage 11,lying lateral group body-wall muscles are now visualized by TmI
dorsal view. nau expression is detected in clusters of cells in theexpression. (H) A deeper focal plane of F, showing an absence of
mesoderm. (D) Ectopic MEF2 embryos, stage 11, dorsal view. nauthe other lateral group body-wall muscles.
expression in the mesoderm is moderately reduced. (E) Wild-type
UAS-mef2 embryo, stage 13, lateral view. nau is expressed in clus-
the pattern of TmI expression. Thus the initial cell-fate ters of cells aligned in three rows in each segment of the body-
determination of the general myoblast population was not wall muscle. (F) Ectopic MEF2 embryo, stage 13, lateral view. nau
expression level in the body-wall muscle is dramatically decreased.markedly affected in these embryos.
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cally expressed MEF2 in the epidermis and the ventral mid-
line cells is not affected. However, the development of nau-
expressing founder cells is defective.
We also examined the expression of MEF2 in these em-
bryos by antibody staining to assess whether the abnormal
body-wall muscle formation resulted from aberrant expres-
sion of MEF2 in the mesoderm and muscles. The expression
of MEF2 by stage 12 in the mesoderm of these embryos was
normal (not shown). In addition, we could not detect any
increase in programmed cell death using acridine orange to
selectively stain apoptotic cells (Abrams et al., 1993). Thus
it appears that ectopic expression of MEF2 in the epidermis
and the ventral midline cells results in the failure of mus-
cles to fuse and differentiate properly to form muscle ®bers.
Ectopic Expression of MEF2 in Epidermis Affects
Epidermal Differentiation and Signaling
of dpp and wg
Several studies have reported that the ectoderm may play FIG. 6. Expression of aPS1 and dei in embryos that ectopically
express MEF2 in the epidermis and the ventral midline cells. Em-an inductive role in muscle development (Beer et al., 1988;
bryos derived from the cross of ¯ies carrying the 69B epidermalBate et al., 1993; Baker and Schubiger, 1995). Thus the ab-
enhancer to ¯ies carrying the UAS-mef2 transgene were assayednormal body-wall muscle formation in the embryos that
for expression of aPS1 (A and B) and dei (C±F) by whole-mount inectopically expressed MEF2 in the epidermis and the ventral
situ hybridization. All embryos are oriented with the anterior tomidline cells is likely due to a disrupted development of
the left. (A) Wild-type UAS-mef2 embryo, stage 12, lateral view.the epidermis. As mentioned previously, the epidermis in
aPS1 expression is detected in the segmental boundaries (arrow). (B)these embryos failed to undergo dorsal closure, suggesting Ectopic MEF2 embryo, stage 12, lateral view. aPS1 expression in the
that the epidermal cells of these embryos lacked the ability segmental boundaries appears normal. The staining of the midgut
to undergo dorsal migration. To assess whether the epider- is out of focus. (C±F) Stage 16, viewed at high magni®cations. (C
mis in these embryos was capable of differentiation, we and E) The lateral and ventrolateral views of a wild-type UAS-mef2
embryo, respectively. dei is expressed in the muscle attachmentexamined the expression of crumbs (crb) and the secretion
sites in the segmental boundaries (arrows) and intrasegmental re-of cuticle. crb encodes an EGF-like protein that is localized
gions (brackets). (D and F) The lateral and ventrolateral views ofon the apical membranes of epithelial cells and is required
an ectopic MEF2 embryo, respectively. The pattern of dei expres-for the organization of epithelial cells (Tepass et al., 1990;
sion in the segmental boundaries (arrows) and intrasegmental re-Grawe et al., 1996). The expression of crb in these embryos
gions (brackets) is diffused and distorted.appeared to be normal (not shown). These embryos also
secreted cuticle as examined by the formation of ventral
denticle belts (not shown) (Struhl, 1989); however, because
these embryos had distorted body walls due to a failure to at stage 8 and becomes concentrated in the segmental
boundaries at later stages (Leptin et al., 1989). The expres-undergo dorsal closure, it was not possible to determine
whether the pattern of ventral denticles was normal. Thus sion pattern of aPS1 in embryos that ectopically expressed
MEF2 in the epidermis appeared to be normal (Figs. 6A andthe epidermis of these embryos was capable of some differ-
entiation in that it could express crb and secreted cuticle 6B). The expression of dei in normal embryos is observed
in a small cluster of cells in the middle of the body-walldespite the fact that MEF2 and other muscle genes were
ectopically expressed in this tissue. segments, which may correspond to epidermal cells that
form intrasegmental clusters of muscle-attachment sitesEctopic expression of MEF2 in the epidermis, however,
may affect the ability of the epidermis to form proper mus- (Armand et al., 1994). Subsequently, dei is expressed in the
muscle-attachment sites in the segmental boundaries. Em-cle-attachment sites, signal the mesoderm to differentiate
to form muscle ®bers, or serve as a matrix for mesoderm bryos ectopically expressing MEF2 in the epidermis showed
what appeared to be normal levels of dei expression; how-migration and myoblast fusion. To test whether embryos
that ectopically expressed MEF2 in the epidermis formed ever, the pattern of expression was slightly diffused and
distorted compared to normal embryos (compare Figs. 6Dproper muscle-attachment sites in the epidermis, we exam-
ined these embryos by whole-mount in situ hybridization and 6F with 6C and 6E, respectively). This might be due to
the irregular shape of epidermal cells and the distortion offor the expression of aPS1 which encodes the a subunit of
epidermal integrin and dei which encodes a bHLH protein. the epidermis resulting from the defect in epidermal migra-
tion and dorsal closure. Thus it appears that muscle-attach-Both of these proteins are expressed in the muscle-attach-
ment sites of the epidermis. In normal embryos, aPS1 tran- ment sites in the epidermis form in these embryos. How-
ever, it is possible that they are not completely normal.script is detected in the presumptive epidermis beginning
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8484 / 6x19$$$203 01-18-97 03:24:43 dbal
249Ectopic Expression of MEF2 in Drosophila Epidermis
7B with 7A). It has been reported that the GAL4/UAS sys-
tem is temperature-sensitive and more extreme phenotypes
are observed when embryos are collected at a higher temper-
ature (297C) (Staehling-Hampton et al., 1994). The level of
expression of dpp in the visceral mesoderm, however, was
unaffected (compare Fig. 7B with 7A).
Several reports have demonstrated that wg plays a role in
intercellular communication (Morata and Lawrence, 1977;
Wieschaus and Riggleman, 1987; Baker, 1988). Indeed, re-
cent studies have shown that WG expressed in the ectoderm
can act as an inductive signal for the initiation of the devel-
opment of subsets of somatic muscles (Baylies et al., 1995;
Ranganayakulu et al., 1996). In normal embryos, wg is ex-
pressed in 14 stripes in the ectoderm at blastoderm andFIG. 7. dpp and wg expression in embryos that ectopically express
MEF2 in the epidermis and the ventral midline cells. Embryos ob- gastrulation and during germ-band extension (Baker, 1988;
tained from the cross of ¯ies carrying the 69B epidermal enhancer van den Heuvel et al., 1989). Before germ-band retraction,
to ¯ies carrying the UAS-mef2 transgene were assayed for expres- the striped pattern of wg expression becomes discontinuous
sion of dpp (A and B) and wg (C and D) by whole-mount in situ and separated into dorsal (Fig. 7C) and ventral (Fig. 7C, not
hybridization. All embryos are stage 13, lateral view, and oriented in focus) sectors. wg expression is also detected in paraseg-
with the anterior to the left. (A) Wild-type UAS-mef2 embryo. dpp ment 8 in the visceral mesoderm after germ-band retractionis expressed in two longitudinal stripes in the epidermis and in
is complete (Fig. 7C). In embryos that ectopically expressedparasegments 4 and 7 of the visceral mesoderm (arrows; out of
MEF2 in the epidermis, wg expression in the dorsal sectorfocus). (B) Ectopic MEF2 embryo. dpp expression in both stripes in
of the epidermis was dramatically reduced in stage 13 em-the epidermis is dramatically decreased, whereas that in the vis-
bryos, whereas that in the ventral sector appeared to be onlyceral mesoderm appears unaffected (arrows; out of focus). (C) Wild-
type UAS-mef2 embryo. wg is expressed in two sectors in the epi- slightly affected (not shown). However, when embryos were
dermis. The ventral sector is not in focus. wg is also expressed in collected at a higher temperature (297C), the reduced expres-
parasegment 8 of the visceral mesoderm (arrow; out of focus). (D) sion of wg in the dorsal sector became more distinct (com-
Ectopic MEF2 embryo. wg expression is dramatically reduced in pare Fig. 7D with 7C), and the expression of wg in the ven-
the dorsal sector and substantially reduced in the ventral sector (not tral sector was substantially decreased (Fig. 7D, out of fo-
in focus) in the epidermis, whereas that in the visceral mesoderm
cus). wg expression in the visceral mesoderm, however, wasappears unaffected (arrow; out of focus).
unaffected (compare Fig. 7D with 7C). These results suggest
that disruption of the epidermal signaling of wg is one of
the factors resulting in the abnormal body-wall muscle for-
mation observed in embryos in which MEF2 is ectopicallyRecent reports have revealed that the epidermal signaling
of dpp, a member of the TGF-b family of secreted growth expressed in the epidermis.
factors (Rijsewijk et al., 1987), and wg, a segment polarity
gene which encodes a secreted protein (St. Johnston and
Misexpression of MEF2 in Mesoderm and MusclesGelbart, 1987), are important for the formation of visceral
Results in a Failure of Myoblast Fusionand body-wall muscles, respectively (Bate and Rushton,
1993; Staehling-Hampton et al., 1994; Frasch, 1995; Baylies Since MEF2 is a transcriptional regulator of TmI expres-
sion and body-wall muscle differentiation, we suspectedet al., 1995; Ranganayakulu et al., 1996). To assess whether
embryos that ectopically expressed MEF2 in the epidermis that its ability to function might be sensitive to its level of
expression in the mesoderm and muscles. The 24B mesoder-are capable of sending signals from the epidermis to the
mesoderm, we examined the expression of dpp and wg in mal enhancer line expresses GAL4 in most, if not all, cells
in the mesoderm starting at stage 10 and then in the somaticthese embryos. dpp is expressed in normal embryos in the
dorsal ectoderm at blastoderm and gastrulation and and visceral muscles and the muscles of the dorsal vessel
(Brand and Perrimon, 1993; Bour et al., 1995). Embryos de-throughout germ-band extension (St. Johnston and Gelbart,
1987). Prior to the start of germ-band shortening, the expres- rived from the cross of ¯ies carrying the 24B mesodermal
enhancer to ¯ies carrying the UAS-mef2 transgene died assion pattern is transformed into two thin horizontal stripes
on each side of the embryo, one stripe of dorsal cells that late embryos. These embryos showed some body-wall
movement; however, analysis of TmI expression in theseborder the amnioserosa, and one stripe of ventrolateral cells
that border the neurogenic ectoderm (Fig. 7A). dpp is also embryos showed an abnormal pattern of body-wall muscles
and several unfused myoblasts expressing TmI were ob-expressed in parasegments 4 and 7 of the visceral mesoderm
starting at this stage (Fig. 7A). In embryos that ectopically served in the body-wall muscles at late stages (compare Fig.
8B with 8A). This phenotype was considerably enhanced inexpressed MEF2 in the epidermis, the expression of dpp in
the two stripes of the epidermis was decreased beginning embryos collected from this cross and raised at 297C. At
the higher temperature embryos had no body-wall move-at stage 12. The decrease was more dramatic when embryos
were collected at a higher temperature (297C) (compare Fig. ment and showed a more profound derangement of body-
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FIG. 8. Overexpression of MEF2 in the mesoderm and muscles leads to abnormal body-wall muscle formation, abnormal expression of
nau, and ectopic expression of DMLP1 in embryos. Embryos derived from the cross of ¯ies carrying the 24B mesodermal enhancer to ¯ies
carrying the UAS-mef2 transgene were collected at 257C (A, B, and E±J) or 297C (C and D) and were assayed for TmI (A±D), nau (E±H),
and DMLP1 (I and J) expression by whole-mount in situ hybridization. All embryos are oriented with the anterior to the left. (A±D) Stage
16, viewed at high magni®cations. (A) Wild-type UAS-mef2 embryo, ventrolateral view, showing TmI expression in the ventral group
muscles (bracket) of the body wall. (B) MEF2 overexpression embryo, ventrolateral view, showing some unfused myoblasts expressing
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wall muscle pattern and many more unfused myoblasts, DISCUSSION
especially in the dorsal group muscles (compare Fig. 8D
with 8C). Therefore, the level of MEF2 in the mesoderm Ectopic Expression of MEF2 in the Epidermis Leads
and/or muscles is critical to myoblast fusion and/or differ- to Activated Transcription of Muscle Genes
entiation and body-wall muscle formation. However, over-
expression of MEF2 in the mesoderm and/or muscles did The experiments presented here demonstrate that ectopic
not have a noticeable effect on the formation of the viscera expression of MEF2 in the epidermis and the ventral mid-
and the dorsal vessel or TmI expression in these two mus- line cells, tissues where MEF2 is not normally expressed,
cles (not shown), suggesting that MEF2 is not a major deter- can activate transcription of TmI and a number of other
minant of the formation of these two muscle types, which muscle genes tested. There are at least three possible mech-
is consistent with previous experiments in analyzing TmI anisms to account for this activation. First, TmI and the
expression in mef2 mutant embryos (Lin et al., 1996). Alter- other muscle genes assayed contain cis-acting regulatory
natively, the level of MEF2 required for the formation of elements that are direct targets for MEF2 and binding of
the visceral muscle and the dorsal vessel is not as critical MEF2 to these sites alone is able to activate transcription.
as it is for the formation of the body-wall muscle. Our previous analysis of TmI enhancer function in
To assess how the body-wall muscle was abnormally transgenic ¯ies has shown that both intron enhancers that
formed in embryos that overexpressed MEF2 in the meso- regulate TmI expression contain MEF2-binding sites and
derm and muscles, we examined the expression of nau and that each of these sites is necessary for enhancer function
S59, which serve as markers for founder cells that give rise in body-wall muscles (Lin et al., 1996). These experiments
to speci®c muscle ®bers. In these embryos, the expression also showed, however, that a MEF2-binding site by itself is
of nau in the mesoderm at stage 11 when nau is normally not suf®cient for transcription in the context of the en-
activated appeared unaffected (compare Fig. 8F with 8E); hancer constructs tested. These studies would suggest that
however, the expression of nau in the developing body-wall MEF2 alone cannot activate TmI, and possibly the other
muscles was substantially decreased by the end of germ- muscle genes tested as well, in the epidermis by binding
band retraction (compare Fig. 8H with 8G). Embryos col- and activation through cognate binding sites. This notion
lected at a higher temperature (297C) from this cross showed is further supported by the fact that not all cells ectopically
a more signi®cant decrease in nau expression by the end of expressing MEF2 activate TmI. For instance, expressing
germ-band retraction (not shown). On the other hand, the MEF2 in the nervous system does not lead to TmI expres-
expression of S59 was normal (not shown). Thus the early sion. We have also noted that the 24B mesodermal enhancer
patterning of nau and S59 muscle precursors was not af- ectopically expresses MEF2 in small groups of cells above
fected by elevated levels of MEF2; however, subsequent dif- the ventral nerve cord and beneath the epidermis on the
ferentiation of nau-expressing cells was affected suggesting ventral side of the embryo and that TmI is not ectopically
that some muscle precursors may be more sensitive to lev- expressed in these cells. Furthermore, ectopically express-
els of MEF2 than others. ing MEF2 in the ectoderm and mesoderm earlier in em-
An interesting observation was made when the expres- bryogenesis does not lead to transcriptional activation of
sion pattern of DMLP1 was analyzed. In embryos that over- TmI until much later than would be expected if TmI expres-
expressed MEF2 in the mesoderm and muscles, the expres- sion were dependent solely upon the presence of MEF2. We
sion of DMLP1 in the somatic muscle was abnormal (not cannot, however, rule out the possibility that ectopically
shown), similar to the phenotypes shown by TmI expres- expressed MEF2 in the nervous system or in the early ecto-
sion. Interestingly, DMLP1 which is not normally expressed derm and mesoderm is somehow present in an inactive form
in the dorsal vessel was ectopically expressed in the dorsal and thus incapable of transcriptional activation.
vessel in embryos overexpressing MEF2 in the mesoderm A second hypothesis is that MEF2 activates a pathway
and muscles (compare Fig. 8J with 8I). That overexpression that leads to transcriptional activation of TmI and other
of MEF2 in the dorsal vessel is able to induce the expression muscle genes. MEF2 mutant embryos do not form body-
of DMLP1 suggests that DMLP1 may be a target of MEF2- wall muscles suggesting that MEF2 is a key regulator of
muscle differentiation (Bour et al., 1995; Lilly et al., 1995;regulated gene expression in muscles.
TmI in the body-wall muscle (arrows). (C) Wild-type UAS-mef2 embryo, dorsolateral view. TmI expression is detected in the dorsal group
muscles (bracket) of the body wall. (D) MEF2 overexpression embryo, dorsolateral view. Many more unfused myoblasts expressing TmI
and a deranged muscle pattern are observed in the body-wall muscle of embryos raised at the higher temperature. (E) Stage 11 wild-type
UAS-mef2 embryo, dorsal view, showing nau expression in clusters of cells in the mesoderm. (F) Stage 11 MEF2 overexpression embryo,
dorsal view, showing nearly normal expression of nau in the mesoderm. (G) Stage 13 wild-type UAS-mef2 embryo, lateral view. nau is
expressed in clusters of cells aligned in three rows in each segment of the body-wall muscle. (H) Stage 13 MEF2 overexpression embryo,
lateral view, nau expression level in the body-wall muscle is substantially decreased. (I) Stage 17 wild-type UAS-mef2 embryo, dorsal
view. DMLP1 is not detected in the dorsal vessel. (J) Stage 17 MEF2 overexpression embryo, dorsal view. Ectopic expression of DMLP1
is observed in the dorsal vessel (arrow).
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Ranganayakulu et al., 1995) and thus ectopic expression of pressed in both the mesoderm and epidermis of later stage
wild-type embryos and is not expressed in the nervous sys-MEF2 might lead to activation of a pathway(s) involved in
regulating myogenesis. There are con¯icting reports on tem. Thus this factor has characteristics of a common factor
that might facilitate ectopic expression of muscle genes inwhether forced expression of vertebrate MEF2A in ®bro-
blasts can activate expression of myogenic bHLH and other the epidermis of late-stage embryos.
That the genes,b3-Tub, nau, aPS2 , and DMLP1, are ectopi-muscle genes and lead to the formation of differentiated
myotubes (Kaushal et al., 1994; Molkentin et al., 1995). cally expressed in the epidermis and/or ventral midline cells
of embryos ectopically expressing MEF2 in these tissuesWe have not observed any morphological changes in the
epidermal cells expressing MEF2 that would suggest that indicates that these genes may also be direct targets of MEF2
or targets of downstream genes that are regulated by MEF2.they are taking on a muscle-like phenotype. In addition, we
have not detected di- or trinucleate clusters of cells about There are as yet no reports of regulation of these genes by
MEF2; however, our results showing that aPS2 might be ato fuse as has been reported for cells ectopically expressing
Twist (Baylies and Bate, 1996). Furthermore, both early em- target of MEF2 are consistent with a report showing that
the aPS2 gene contains a binding site for MEF2 and thatbryos ectopically expressing MEF2 by heat-shock treatment
in the ectoderm prior to epidermal differentiation and later the aPS2 transcript is not detected in mef2 mutant embryos
(Ranganayakulu et al., 1995). Although ectopic expressionstage embryos expressing MEF2 under the control of the 69B
enhancer show some functional epidermal differentiation in of MEF2 in the ventral midline cells is able to activate the
expression of DMLP1 in this tissue, ectopic expression ofthat the epidermis expresses crumbs, an EGF-like molecule
required for epithelial organization, secretes cuticle, and MEF2 in the epidermis is unable to activate the epidermal
expression of DMLP1. This suggests that the ectopicallyexpresses markers indicative of muscle-attachment sites.
Therefore, the cell fate of the epidermis has not been dra- expressed MEF2 in these two ectodermal derivatives is act-
ing differently to activate DMLP1 than it is to activate TmI,matically changed by ectopic expression of MEF2 in this
tissue. The epidermis, however, is affected in that the epi- b3-Tub, nau, and aPS2 . In addition, not all epidermal cells
respond the same to ectopically expressed MEF2 becausedermal cells fail to migrate dorsally to undergo dorsal clo-
sure and fail to form some epidermal-derived organs, such nau and aPS2 are ectopically expressed primarily on the ante-
rior dorsal epidermis, whereas TmI and b3-Tub are ex-as the trachea and the ®lzkorper. It is possible that by the
time ectopic MEF2 is expressed and accumulated to high pressed more uniformly throughout the epidermis. These
differences may re¯ect differences in the abilities of epider-enough levels to have an effect on the epidermal precursors,
their fates to undergo epithelial organization, secrete cuti- mal cells in different regions of the embryo to respond to
ectopically expressed MEF2 or that muscle genes are sensi-cle, and form muscle-attachment sites have been deter-
mined while their fates to undergo dorsal closure and form tive to different levels of ectopically expressed MEF2 and/or
other factors that might be necessary in different epidermalthe trachea and ®lzkorper are determined later. Some of
these phenotypes may be in part related to the decreased cells.
amounts of DPP made in the epidermis. For instance, the
incomplete dorsal closure in these embryos is similar to
Requirement for the Epidermis in Myogenesisthose caused by mutations in genes involved in the dpp
signaling pathway (Arora et al., 1995). Our results showing that ectopic expression of MEF2 in
the epidermis of embryos leads to abnormal muscle forma-A third possibility is that an additional factor(s) in the
epidermis is required to act with MEF2 to induce ectopic tion suggest a requirement for the epidermis in myogenesis.
Several studies have indicated that the ectoderm may playexpression of TmI and the other muscle genes tested. For
instance, it has been shown that vertebrate MEF2 acts coop- a role in muscle development. For instance, transplantation
experiments have shown that muscle formation might beeratively with myogenic bHLH proteins to activate skeletal
muscle genes (Molkentin et al., 1995). This notion suggests induced by ectoderm (Beer et al., 1988). Analyses of neuro-
genic mutant embryos have also suggested a role for thethat the epidermis contains a factor(s) in common with the
mesoderm that can act in conjunction with ectopically ex- ectoderm in muscle development because myoblast fusion
in these embryos is restricted to regions of the mesodermpressed MEF2 to induce TmI expression. Indirect support
for this notion comes from the fact that we do not observe underlying the residual epidermis caused by the hyperplasia
of the nervous system (Bate et al., 1993). In addition, a re-ectopic expression of muscle genes in the epidermis prior
to stage 12 or in the nervous system. Furthermore, in our cent study by arresting gastrulation in Drosophila embryos
has also revealed that muscle determination depends onstudies on TmI regulation we have shown that transcription
activation by MEF2 requires a second regulator region called signals provided by the ectoderm (Baker and Schubiger,
1995).the muscle activator region (Gremke et al., 1993; Lin et al.,
1996). Moreover, recent studies in one of our laboratories WG secreted by the ectoderm has been shown to act as
an inductive signal for the formation of subsets of body-have identi®ed a novel transcription factor that binds to a
cis-element within the muscle activator region and regu- wall muscles (Baylies et al., 1995; Ranganayakulu et al.,
1996). Thus the decreased level of wg expression in embryoslates at least in part the function of the muscle activator
region possibly by interacting with MEF2 (S.-C. Lin and that ectopically express MEF2 in the epidermis is likely to
be responsible in part for the reduced number of body-wallStorti, unpublished data). Interestingly, this factor is ex-
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muscle ®bers and the abnormal patterning of the muscle tion (Ranganayakulu et al., 1995). It is likely that too high or
too low a level of MEF2 will affect concentration-dependent®bers that are formed in these embryos. Although WG se-
creted by the ectoderm has been shown to act as an induc- interactions among factors that regulate enhancer function
and myogenesis.tive signal for the formation of S59-expressing founder cells
(Baylies et al., 1995), embryos that ectopically express MEF2
in the epidermis show a normal expression pattern of S59
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